Technical Analysis for EDIT - Editas Medicine, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Centerline Cross | Bearish | 0.00% | |
New Downtrend | Bearish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Volume Surge | Other | -5.04% | |
NR7 | Range Contraction | -5.04% | |
Narrow Range Bar | Range Contraction | -5.04% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 10 hours ago |
Down 5% | about 10 hours ago |
Down 3% | about 16 hours ago |
Fell Below Previous Day's Low | about 16 hours ago |
Down 2 % | about 16 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Genetics Genetic Engineering Enzymes Genome DNA CRISPR Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Genetics Genetic Engineering Enzymes Genome DNA CRISPR Genome Editing Cas9
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.9 |
52 Week Low | 6.0799 |
Average Volume | 1,885,178 |
200-Day Moving Average | 8.66 |
50-Day Moving Average | 8.35 |
20-Day Moving Average | 8.83 |
10-Day Moving Average | 8.64 |
Average True Range | 0.62 |
RSI (14) | 40.83 |
ADX | 25.52 |
+DI | 22.33 |
-DI | 24.53 |
Chandelier Exit (Long, 3 ATRs) | 9.72 |
Chandelier Exit (Short, 3 ATRs) | 9.48 |
Upper Bollinger Bands | 10.68 |
Lower Bollinger Band | 6.98 |
Percent B (%b) | 0.2 |
BandWidth | 41.86 |
MACD Line | -0.04 |
MACD Signal Line | 0.15 |
MACD Histogram | -0.1833 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 8.40 | ||||
Resistance 3 (R3) | 8.46 | 8.31 | 8.28 | ||
Resistance 2 (R2) | 8.31 | 8.13 | 8.27 | 8.24 | |
Resistance 1 (R1) | 8.01 | 8.03 | 7.94 | 7.95 | 8.21 |
Pivot Point | 7.86 | 7.86 | 7.82 | 7.82 | 7.86 |
Support 1 (S1) | 7.56 | 7.68 | 7.49 | 7.50 | 7.23 |
Support 2 (S2) | 7.41 | 7.58 | 7.37 | 7.20 | |
Support 3 (S3) | 7.11 | 7.41 | 7.16 | ||
Support 4 (S4) | 7.05 |